Rebekka E. Hom

Rebekka Hom practices at Pioneer Physicians Network, Inc. in Uniontown, Ohio.

Rebekka Hom's NPI, 1659634657, was assigned on June 25, 2012. Rebekka Hom holds Ohio license 35.127043.

Rebekka Hom's primary practice is Pioneer Physicians Network, Inc., at 3515 Massillon Rd, Uniontown, OH 44685 in Stark County. The practice phone is (330) 899-9350.

Rebekka Hom's primary practice is Pioneer Physicians Network, Inc. in Uniontown, Ohio. Rebekka Hom is also affiliated with Cleveland Clinic Akron General. The medical group on file is Pioneer Physicians Network. Dmand AI also links Rebekka Hom to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rebekka Hom practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Rebekka Hom's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Rebekka Hom is licensed in Ohio.

CMS data shows 34 Medicare services from Rebekka Hom across 2 procedure codes in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $2,568 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Rebekka Hom in 2024. The largest group is 65 to 74, with 23 patients. 74% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rebekka Hom's median patient age at 59, with 69% women.

In 2024, Rebekka Hom wrote 1,608 Medicare Part D claims for 337 patients. 87% of them were for generic drugs. CMS names the drug for 1,183 of them, across 39 drugs with 11 or more claims each, at $90,652 in total drug cost. In 2023, CMS named 7,928 claims across 127 drugs.

Rebekka Hom accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 64 general payments to Rebekka Hom from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $210.